This is a rare heart problem that can happen when a type of cancer, called a carcinoid tumor, spreads to the liver. The tumor releases chemicals, like serotonin, that can make scar tissue build up inside the heart's valves. This scar tissue can make the valves stiff and leaky, causing problems with blood flow to the lungs.
Every report comes from a Lived member, sent anonymously.
Have you had Heart Valve Replacement for Carcinoid Heart Disease?
Carcinoid heart disease is damage to the heart valves caused by hormones released from certain neuroendocrine tumors (NETs), uncommon and often slow-growing cancers that most often start in the small intestine. Some of these tumors release large amounts of serotonin and related substances into the blood. Over years, these substances cause stiff, scar-like plaques to build up on the valves on the right side of the heart, mainly the tricuspid valve (between the two right chambers) and the pulmonary valve (where blood leaves the heart for the lungs). Scarred valve leaflets become thickened, shortened and fixed in place. They can no longer close properly, so blood leaks backward, and less often they narrow and hold back flow. The right side of the heart has to work harder, and over time this can lead to right-sided heart failure: tiredness, shortness of breath, and fluid that collects in the legs and abdomen. Because it strongly affects how well people with carcinoid syndrome do, specialists try to find it before it causes symptoms.
Carcinoid heart disease develops almost only in people who have carcinoid syndrome, a pattern of symptoms such as flushing of the face and chest and frequent watery diarrhea, caused by hormones from a neuroendocrine tumor. Estimates vary widely, but roughly a quarter to two-thirds of people with carcinoid syndrome eventually develop heart involvement. The usual setting is a tumor that has spread to the liver. Normally the liver breaks down serotonin from the gut before it reaches the heart. Tumor deposits in the liver, however, release hormones straight into the veins that drain to the heart, so the right-sided valves are exposed at full strength. The lungs then break down much of what remains, which is why the valves on the left side are usually spared. Left-sided damage can occur with very high hormone levels, a tumor that started in the lung, or a small opening between the upper heart chambers (a patent foramen ovale) that lets some blood bypass the lungs. The more serotonin a tumor produces, the higher the risk. People whose serotonin breakdown product, 5-HIAA, is high are more likely to develop heart involvement and to see it worsen.
Many people have no heart symptoms even when a valve is leaking badly, so the condition is usually found by screening people already known to have carcinoid syndrome rather than by waiting for symptoms. Two tests help decide who needs a closer look at the heart. NT-proBNP (N-terminal pro B-type natriuretic peptide) is a blood test for a substance the heart releases when its walls are under strain. Cardiology and neuroendocrine expert guidance treats a level above 260 pg/mL as a reason to examine the heart, while a normal level makes significant carcinoid heart disease unlikely. Age, kidney function, an irregular rhythm such as atrial fibrillation and other heart problems can also raise it, so the number is read in context. 5-HIAA (5-hydroxyindoleacetic acid) is what the body turns serotonin into. It is measured in urine collected over 24 hours, which means avoiding serotonin-rich foods beforehand, or in a blood sample. A urine level of 300 micromoles (about 57 mg) per 24 hours or more is linked to a two- to threefold higher risk and is a common threshold for screening. The diagnosis itself is made with an echocardiogram, an ultrasound of the heart. It shows thickened, stiff leaflets that do not move normally, how much blood is leaking backward and how well the right ventricle (the right pumping chamber) is coping. A leaking tricuspid valve is found in nearly everyone with the condition, and the pulmonary valve is often involved too. Cardiac MRI or CT may be added, especially to see the pulmonary valve clearly or to plan surgery. Recommendations on how often to repeat the echocardiogram range from every few months to every few years, depending on test results and how high the risk is.
Treatment has two jobs: lowering the hormone output that damages the valves, and managing the heart damage already present. No medicine reverses valve scarring once it has formed, so controlling hormones aims to protect the valves from further harm. Somatostatin analogs are usually the first treatment for carcinoid syndrome. These injected medicines, octreotide (Sandostatin, including the monthly Sandostatin LAR Depot) and lanreotide (Somatuline Depot), imitate a natural hormone that dampens hormone release from the tumor, and they can also slow tumor growth. They ease flushing and diarrhea in about two-thirds of people, although they bring 5-HIAA down in fewer than half. When symptoms or hormone levels stay high, other options include telotristat ethyl (Xermelo), a tablet that reduces the body's production of serotonin and is approved for carcinoid diarrhea that a somatostatin analog has not controlled; peptide receptor radionuclide therapy (PRRT), a radioactive treatment that targets tumor cells; everolimus, a targeted cancer medicine; and procedures that remove liver tumors or cut off their blood supply. The choice depends on where the tumor is, how much there is and overall health. Whether these treatments specifically slow heart damage is still being studied. Diuretics (water pills) are the main treatment for fluid buildup and breathlessness from right heart failure. They relieve symptoms but do not repair the valves. For severe, symptomatic valve disease, valve replacement surgery is the only treatment that corrects the problem. The tricuspid valve is usually replaced, often together with the pulmonary valve. Surgeons generally prefer tissue (bioprosthetic) valves, because mechanical valves require lifelong blood thinners, a greater concern for people whose liver disease already raises bleeding risk. Surgery can relieve symptoms and improve the outlook for people who recover well, but it carries real risk: in pooled studies about 1 in 10 people died within a month, and some people need a permanent pacemaker afterward. The team weighs timing carefully, since the right ventricle may not fully recover even with a new valve, and the decision also depends on the outlook for the cancer itself. For people too frail for open-heart surgery, replacing the valve through a catheter is a newer option with only limited experience so far. Anesthesia, surgery and some tumor treatments can set off a carcinoid crisis, a sudden surge of hormones that causes dangerous swings in blood pressure, intense flushing and wheezing. Teams prevent it by giving octreotide into a vein before, during and after the procedure. Care works best at an experienced center where cancer specialists, cardiologists, heart surgeons and anesthesiologists plan together.
Carcinoid heart disease usually develops gradually and silently, and once present it tends to progress, especially if hormone levels stay high. People with carcinoid syndrome who develop heart involvement live, on average, considerably shorter lives than those who do not, which is why regular screening matters even when someone feels well. Outlook depends on two things together: how much the valves and right ventricle are affected, and how the underlying tumor behaves, since many neuroendocrine tumors grow slowly over years. Day to day, people often live with the effects of both the syndrome and the heart: fatigue, breathlessness with exertion, and swelling that rises and falls with diuretic doses. Follow-up usually means repeated NT-proBNP and 5-HIAA tests, regular echocardiograms, ongoing somatostatin analog injections, and visits with both the cancer team and a cardiologist. After valve surgery, many people breathe and move much more easily, but the new valve is still exposed to the tumor's hormones and keeps being checked, because replacement valves can wear out faster when hormone levels remain high.
If you have a neuroendocrine tumor with carcinoid syndrome, ask whether you have had NT-proBNP and 5-HIAA testing and a baseline echocardiogram, and keep up with repeat screening even when you feel well. Contact your care team soon if you notice new or increasing shortness of breath, tiredness with ordinary activity, swelling in your legs or ankles, or a belly that is swelling with fluid, since these can be the first signs that the right side of the heart is struggling. Before any surgery, liver procedure or anesthesia, make sure every team involved knows you have carcinoid syndrome so they can plan protection against a carcinoid crisis.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Carcinoid Heart Disease is like, what's helped you, or ask the community a question.